516 results about "Chronic rhinitis" patented technology

A Chinese medicine for treating acute and chronic rhinitis, allergic rhinitis, secondary nasosinusitis, etc and preventing cold, asthma and myocardial infarction is prepared from 32 Chinese-medicinal materials including xanthium fruit, sunned ginseng, dried earthworm, borneol, etc.

The invention discloses a composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt and a preparation method of the composite antibacterial agent. The composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt comprises the following raw materials by weight percent: 0.3-0.6% of chitosan, 0.1-2% of organosilicone quaternary ammonium salt, 0.02-0.5% of antibacterial auxiliary, 2-6% of PH adjustor and the balance of purified water. The composite antibacterial agent is prepared by using medical chitosan and organosilicone quaternary ammonium salt as the main components and the antibacterial adjuvant as the adjuvant, the biocompatibility of the original materials are maintained; and the polymeric material is good in bactericidal performance, quick-acting, long-acting, broad spectrum, stable and safe in antibacterial and anti-drug-resistant effect; the composite antibacterial agent can be used for preventing and treating common diseases such as chronic rhinitis, canker sore, colpitis, cervicitis, haemorrhoids, burn scald and trauma, the therapeutic biological antibacterial agent is provided with excellent dual-function of sterilizing and repairing. The composite antibacterial agent disclosed by the invention is good in sterilizing and repairing performance and wide in applicable range.

An aqueous liquid preparation of the present invention containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof, an alkyl aryl polyether alcohol type polymer such as tyloxapol, or a polyethylene glycol fatty acid ester such as polyethylene glycol monostearate is stable. Since even in the case where a preservative is incorporated into said aqueous liquid preparation, the preservative exhibits a sufficient preservative effect for a long time, said aqueous liquid preparation in the form of an eye drop is useful for the treatment of blepharitis, conjunctivitis, scleritis, and postoperative inflammation. Also, the aqueous liquid preparation of the present invention in the form of a nasal drop is useful for the treatment of allergic rhinitis and inflammatory rhinitis (e.g. chronic rhinitis, hypertrophic rhinitis, nasal polyp, etc.).

The invention discloses a pharmaceutical composition for curing allergic rhinitis. The pharmaceutical composition is mainly prepared by extracting the following effective components of a dozen of medical materials including white peony root, astragalus root, white atractylodes rhizome, ledebouriella root, Chinese angelica, magnolia flower, schisandra fruit, grassleaved sweetflag rhizome, cicada slough, liquorice, asarum, dark plum, cocklebur fruit, and the like. The specific active components of the pharmaceutical composition have the effects of strengthening spleen and supplementing qi, warmly nourishing kidney-yang and stopping tears and have remarkable therapeutic effects of curing the rhinitis and various symptoms such as acute and chronic rhinitis, paranasal sinusitis, sicca and atrophic rhinitis, and the like caused by common cold and other reasons.

The invention relates to a formula of a drug for treating rhinitis. The drug is a tea-bag type composite oral preparation and is utilized for treating acute and chronic rhinitis, nasosinusitis and prosopantritis. The drug for treating rhinitis comprises the following ingredients of angelica sinensis, radix astragali, rhizoma atractylodis macrocephalae, fangshui, keel, oyster, cassia twig, ligusticum wallichii, dahurian angelica root, ligusticum sinense oliver, cimicifuga foetida, flos magnoliae, monkshood, sparganium, curcuma rhizome, catnip, notopterygium root, levisticum, chrysanthemum, radix scrophulariae, radix bupleuri, cape jasmine fruit, the bulb of fritillary, xanthium, white peony root, little lotus, asarum herb, rhizoma anemarrhenae, silver flower, honey-fried licorice root, radix glehniae, poria cocos, tuber of dwarf lilyturf, root of large-flowered skullcap, gentian and mulberry leaf. Through many years of clinical application, the formula based on an ancestral "Bizutang" formula is obtained after modification. Through synergistic effects of the ingredients of the drug for treating rhinitis, the effects of tonifying qi and nourishing yin, promoting and tonifying the lung, activating blood circulation and dissipating blood stasis, clearing heat and draining dampness, reducing swelling and relieving pain, and restoring consciousness and unblocking orifices are obtained. The drug for treating rhinitis has the characteristics of obvious curative effects and convenient drug taking way.

The invention provides a Chinese medicinal composition for treating rhinitis and nasosinusitis, which consists of the following 15 Chinese medicinal raw materials: biond magnolia flower, Siberian cocklour fruit, angelica dahurica, manchurian wildginger, Szechuan lovage rhizome, India madder root, root of red-rooted salvia, schizonepeta, divaricate saposhnikovia root, chrysanthemum, honeysuckle flower, weeping forsythia, liquoric root, white paeony root and gambir plant. Simultaneously, the invention provides a preparation process for the Chinese medicinal composition for treating the rhinitis and the nasosinusitis. Clinical experiments prove that the Chinese medicinal composition is safe and effective, is suitable for relieving symptoms such as dizziness, fullness in head, nasal obstruction, rhinocnesmus, sneeze, thin nasal discharge and the like which are caused by the rhinitis and is suitable to be administrated by patients who suffer from chronic rhinitis, allergic rhinitis and the nasosinusitis for a long time.

The invention discloses a rhinitis treatment medicine. The medicine is a medicinal composition prepared by carrying out certain technologies of raw materials comprising pure natural plants, animals and other materials. The medicine has the characteristics of carrying convenience, realization of use at all times and places, suitableness for inpatient adults and inpatient children, self operation for above six-year-old children, fast absorption, high bioavailability, high curative effects and no toxic side effects on acute and chronic rhinitis, nasosinusitis and allergic rhinitis through a large amount of clinical applications, and no recurrence after curing. The rhinitis treatment medicine has the advantages of wide sources of the used raw materials, low cost, simple preparation method, and no discharge of three wastes in the production process.

The invention relates to a Chinese medicinal spraying agent for noses. The spraying agent of 1, 000 milliliters is prepared by 200 to 400 grams of sauted fructus xanthil, 50 to 150 grams of lily magnolia, 100 to 300 grams of angelica dahurica, 50 to 150 grams of centipeda herb, 200 to 400 grams of mint, 200 to 400 grams of radix scutellariae, and 50 to 150 grams of liquorice. In the formulation, the radix scutellariae and the fructus xanthil mainly aim at disease causes to clear wind heat and relieve stuffy nose; the mint, the angelica dahurica, the lily magnolia, the centipeda herb and the like are used for dissipating wind evil, relieving stuffy nose, and aiming at disease symptoms to relieve the symptoms; the liquorice is used for coordinating each drug; 'monarch, minister, assistant and guide' are clear; the main treatment efficacies are definite; and the spraying agent is a good agent for clearing wind heat and relieving stuffy nose, and is used for external wind heat or chill heat, stuffy nose and nasal discharge, headache and lacrimation, and acute and chronic rhinitis.

A traditional Chinese medicine for remedying various kinds of rhinitis belongs to the traditional Chinese medicine for remedying the rhinitis. The traditional Chinese medicine consists of 10g of Siberian cocklebur fruits, 60g of dahurian angelica roots, 60g of biond magnolia flowers, 6g of borneol powder, 5g of corn mint scream, 500 milliliters of sesame oil and 1000 milliliters of liquid paraffine. The traditional Chinese medicine mainly remedies the acute rhinitis, the chronic rhinitis, the atrophic rhinitis and the allergic rhinitis. The dosage materials in the prescription are all made from natural traditional Chinese herbal medicines by a traditional processing method. The materials can be easily gotten; the prescription and the preparation method are simple; the expense for preparing the medicine is low. The compatibility of the traditional Chinese herbal medicines is simple; the medicines used in the medicine prescription are all natural herbal medicines which can be conveniently gotten and used; the manufacturing method is simple; the curative effect after being taken is good; the medicine price is cheap, and the medicine is especially fit for people who live at the remote small villages away from villages and towns to use. The treatment expense for the patient with the disease of various kinds of rhinitis is low, which solves the treatment problem which is caused by low family income, poor living and lack of local medical treatment condition.

The invention provides a medicament for treating chronic rhinitis and nasal sinusitis, which is prepared from dandelion, honeysuckle flower, siberian cocklebur fruit, baikal skullcap root, asarum herb and magnolia flower.

The Chinese medicine powder for treating nasosinusitis as well as rhinitis, chronic rhinitis, erosive nasal septum is prepared with 18 kinds of Chinese medicinal materials including thunberg fritillary bulb, Chuanxiong rhizome, glabrousleaf pittosporum seed, flavescent sophora root, dahurian angelica root, etc. which are produced into medicine powder and capsulized. The medicine has high curative effect and no toxic side effect.

The invention discloses a herbal stoste atomization liquid with essences. The herbal stoste atomization liquid is applied to electronic cigarette, an aromatherapy diffuser, a humidifier and a nano ultrasonic atomizer. The liquid comprises 1-100 parts by weight of a herbal stoste atomization liquid and 1-20 parts by weight of essences. Herbal stostes are adopted as raw materials, no chemical spicespopular in the market are used, and thus no harm can be done to bodies. The herbal stoste atomization liquid adopts herbs as raw materials, no chemical spices popular in the market are used, and thusno harm can be done to bodies. The herbal stoste atomization liquid is capable of effectively relieving rhinitis (allergic rhinitis and acute or chronic rhinitis), respiratory tracts, sleep, heart and cerebral vessels, ozostomia and the like. The herbal stoste atomization liquid can be not only used as electronic cigarette oil, but also directly sprayed to mouths and noses to be absorbed and usedby using various nano atomizers.

A Chinese medicine in the form of oral liquid for treating rhinitis and nasosinusitis is prepared from 15 Chinese-medicinal materials including ledebouriella root, magnolia flower, asarum herb, houttuynia, etc through extracting, mixing and regulating concentration. Its advantages are high curative effect (98.9% for total effective rate) and quickly taking its effect.

The invention provides a medicinal composition for treating rhinitis. The medicinal composition is prepared from the following raw materials in parts by weight: 5-15 parts of magnolia flower essential oil, 2-8 parts of centipeda minima essential oil, 1-5 parts of mint essential oil, 2-8 parts of agastache rugosa essential oil, 2-8 parts of wild chrysanthemum essential oil, and 1-5 parts of cassia twig essential oil. The invention further provides a preparation method and application of the composition. The study results show that the medicinal composition has a good therapeutic effect on chronic rhinitis and allergic rhinitis, is precise and appropriate in compatibility, and obviously superior to the medicinal composition with a different formula in pharmacological activity; meanwhile, the medicinal composition is not required to be orally taken or injected, so that the patient compliance is better and a novel choice is provided for clinical medication.

The invention relates to a preparation method of ampelopsis grossedentata tea. The preparation method comprises the steps of: selecting tender branches and leaves of ampelopsis grossedentata, putting the branches and the leaves into a pot, carrying out hand-grabbing and stir-frying, quickly raising the temperature to 70-80 DEG C for 3-4min, wherein the tender branches and leaves are hot in hand feel and scald hands; reducing the temperature to 45-55 DEG C, carrying out pan-frying by using a tea drag until stuffy droplet crackles occur, frying to be semi-dried and discharging; lightly pressing and then airing for cooling, placing in a twisting machine, sizing and dissolving block masses; placing in an automatic chain plate type dryer for drying, primarily drying for 0.5-1h, and controlling the temperature to be 120-130 DEG C; in order to prevent the condition that the ampelopsis grossedentata is externally dried and internally wet, spreading for cooling the ampelopsis grossedentata for 0.5-1h after primary drying, and then sufficiently drying, controlling the temperature to be 115-120 DEG C until the water content of the ampelopsis grossedentata reaches 6-7 percent; and spreading for cooling, sterilizing and packaging. The ampelopsis grossedentata is pan-fried by using the hot pot, then twisted by using the twisting machine, and dried by using the automatic chain plate type dryer, thereby ensuring pure color and taste; the ampelopsis grossedentata tea is few in nutrient loss, and can be directly taken; and the ampelopsis grossedentata tea has remarkable effect on treatment of chronic rhinitis, chronic pharyngitis and chronic laryngitis.

The invention relates to a traditional medicine composite for treating chronic rhinitis, wherein compared with present technique, it is fried via 18-22 deals of gingelly oil into oil, and it comprises 4.0-4.5 deals of xanthostrumarin, 0.8-1.2 deals of magnolia flower, and 1.8-2.2 deals of dahurian angelica root. The invention has wide application and low cost.

The invention discloses a medicine for treating acute and chronic rhinitis and sinusitis which comprises the raw materials based on the parts by weight: 2-6 parts of beautiful sweetgum fruit, 2-6 parts of white gourd kernels, 2-6 parts of pericarpium trichosanthis, 2-5 parts of hawksbill carapace, 3-8 parts of herba lycopi, 1-5 parts of cordate houttuynia, 2-6 parts chastetree fruit, 0.3-0.8 partof fructus gleditsiae, 1-4 parts of centipeda minima, 0.5-1.5 parts of asarum heterotropoides, 3-8 parts of fried fructus xanthii, 3-9 parts of biond magnolia flower, 2-6 parts of angelica anomala, 3-8 parts of north ligusticum, 2-6 parts of scutellaria baicalensis, 2-6 parts of flos chrysanthemi indici, 3-8 parts of szechuan lovage rhizome and 1-5 parts of liquorice. The medicine selects the rawmaterials with unique and reasonable mixture ratio, and has the effects of dispelling wind and heat, clearing away heat and toxic material, promoting diuresis, nourishing lung and promoting the restoration consciousness as well as relieving pain of brain and eyes, thus effectively treating symptoms such as rhinobyon, yellow thick nasal mucus, headache, dizziness, hypomnesis and the like caused bythe acute and chronic rhinitis and sinusitis.

The invention discloses Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis. The Chinese medicinal magnolia flower and angelica dahurica powder comprises the following Chinese medicinal components in part by weight: 14 to 16 parts of magnolia flower, 29 to 31 parts of angelica dahurica, 14 to 16 parts of mint and 6 to 8 parts of siberian cocklour fruit (fried). The common pure Chinese medicines are taken as components, and are reasonably compatible; the Chinese medicinal magnolia flower and angelica dahurica powder does not have toxic or side effects, and is convenient to use; and when the powder is orally taken, an optimal effect can be achieved.

The invention discloses a traditional Chinese medicine composition for treating sinusitis. The medicine composition is prepared from the following components: 120 to 150g of scutellaria, 120 to 150g of gypsum, 50 to 80g of radix bupleuri, 120 to 150g of honeysuckle, 120 to 150g of radix sileris, 120 to 150g of fructus viticis, 180 to 220g of fried fructus xanthii, 120 to 150g of angelica, 50 to 80g of flos magnoliae liliflorae, 50 to 80g of herba centipedae, 50 to 80g of chrysanthemum, 50 to 80g of bombyx batryticatus, 50 to 80g of scorpio, and 120 to 150g of licorice. The medicine composition has the functions of dispelling wind and dispersing dampness, detoxicating and resolving a mass, unblocking orifice and stopping pain, and treating chronic rhinitis, sinusitis and allergic rhinitis. The formulation has the advantages of good curative effect, economy, no trauma and no obvious toxic and side effects, and easily cures the sinusitis.

The present invention discloses a traditional Chinese medicine compound preparation for treating rhinitis, the preparation is composed of 14 traditional Chinese medicine raw materials of siberian cocklour fruit, biond magnolia flower, dahurian angelica root, wild chrysanthemum, Chinese magnoliavine fruit, fineleaf schizonepeta herb, platycodon root, divaricate saposhnikovia root, liquoric root, amur corktree bark, common anemarrhena rhizome, weeping forsythiae capsule, ephedra herb and manchurian wildginger. The clinical efficacy and safety evaluations show that the present invention is safe and effective for the treatment of acute and chronic rhinitis. The present invention provides the preparation method.

The invention discloses a Chinese medicinal mixture for treating chronic rhinitis. The Chinese medicinal mixture comprises the following Chinese medicinal components in part by weight: 8 to 10 parts of bupleurum root, 8 to 10 parts of mint, 8 to 10 parts of chastetree fruit, 8 to 10 parts of parsnip, 8 to 10 parts of schizonepeta spike, 8 to 10 parts of skullcap root, 8 to 10 parts of platycodon root, 8 to 10 parts of Szechuan lovage rhizome, 8 to 10 parts of dahurian angelica root, 8 to 10 parts of biter orange, 80 to 100 parts of cattle horn, 4 to 5 parts of asarum, 4 to 5 parts of gentian root and 12 to 15 parts of magnolia flower. The components are common pure Chinese medicaments, and the compatibility is reasonable, so the Chinese medicinal mixture has no toxic or side effect; and the Chinese medicinal mixture has better effect on oral administration and external application on the aspect of use.

The invention belongs to the technical field of Chinese herbal preparations, and particularly relates to paste for treating rhinitis and a preparation method thereof. The paste for treating rhinitis mainly comprises active ingredients and auxiliary materials such as honeysuckle, magnolia flower, cocklebur fruit, radix angelicae, calamine, tsuchiuri root powder, borneol, radix paeoniae rubra, radices lithospermi, schizonepeta, divaricate saposhnikovia root, yam rhizome, felwort, rhizoma alismatis, scutellaria baicalensis, golden cypress, poria cocos, dried radix rehmanniae, cortex moutan, akebiaquinata, semen plantaginis, fructus kochiae, dittany bark, licorice roots northwest origin, semen coicis and lalang grass rhizome, through the effective and reasonable matching and synergism and promotion of the ingredients, the paste with the remarkable medicine effect and specially for rhinitis is obtained and suitable for acute and chronic rhinitis and allergic rhinitis, the nasal mucosa can be protected and repaired, the effects of quickly relieving symptoms and curing diseases are achieved, and the effective effect of treating both symptoms and root causes is achieved.

The invention relates to a Chinese medicine composition for treating chronic rhinitis. The Chinese medicine composition comprises the following raw medicinal materials in parts by weight: 10-40 parts of honeysuckle, 10-30 parts of fructus forsythiae, 10-30 parts of cordate houttuynia, 5-15 parts of astragalus membranaceus, 10-30 parts of ligusticum wallichii, 10-40 parts of radix angelicae, 5-15 parts of magnolia flower, 5-15 parts of chrysanthemum, 5-15 parts of cocklebur fruit, 5-15 parts of platycodon grandiflorum, 5-15 parts of schizonepeta, 5-15 parts of mint, 5-15 parts of radices sileris, 5-15 parts of radix bupleuri, 3-10 parts of liquorice, 5-15 parts of gypsum, 5-15 parts of cicada slough and 5-15 parts of stiff silkworm. The Chinese medicine composition disclosed by the invention has the effects of clearing away heat, purging pathogenic fire, dispelling wind and heat, opening the inhibited lung-energy, freeing orifice, reducing phlegm and resolving masses, has a remarkable treatment effect on chronic rhinitis, is reliable in action, is well-sourced in medicinal components, is simple and convenient to prepare, and causes no toxic and side effects.

A Chinese medicine in the form of dripping pill, dispersing tablet, or micropill for treating chronic rhinitis and nasosinusitis is prepared from xanthium fruit, honeysuckle flower, wild chrysanthemum flower, magnolia flower and madder. Its preparing process and quality control method are also disclosed.

The invention provides a Chinese medicament for treating rhinitis, which is prepared from Xanthium sibiricum seeds 200-400g, magnolia flower 50-150g, dahurian angelica root 100-300g, centipede 50-150g, spearmint 200-400g, baikal skullcap root 200-400g and licorice root 50-150g.

The invention discloses an external medicament for treating rhinitis, and relates to the technical field of medicaments, in particular to an external medicament for treating acute and chronic rhinitis. The external medicament consists of the following ingredients in parts by weight: 800 g of cocklebur fruit (cracked), 400 g of flower bud of lily magnolia, 70 g of angelica root, 80 g of scutellaria baicalensis, 60 g of corktree, 300 g of honey, 70 g of coriander (washed), 60 g of cordate houttuynia (washed), 5 g of borneol fine powder and 5 g of mint cream. The medicament can be used for treating various kinds of rhinitis, has the effects of clearing heat and toxin, opening nasal numbness and repairing nasal mucosa, and has a good curative effect on all symptoms such as rhinocnesmus, cough, snuffle, nasal cavity dryness, sneezes, clear or yellow nasal discharge.

The invention discloses a Chinese medicinal composition for treating pollen hypersensitivity which mainly comprises the following components (by weight portion): astragalus root 1-3 part, pilose asiabell root 1-3 parts, root of Dahurain angelica 0.3-1 part, silver flower 0.3-1 part, mulberry leaf 0.3-1 parts. The composition can be used for improving humen immunocompetence and enhancing ability to fight diseases.

The invention belongs to the technical field of drugs, and particularly relates to a drug for treating acute or chronic rhinitis. The drug is characterized by being prepared from the following raw materials in parts by weight: 20-30 parts of cocklebur fruits, 10-14 parts of radix angelicae, 8-10 parts of flower bud of lily magnolia, 8-10 parts of borneol, 7-9 parts of menthol, 5-7 parts of sesame oil and 3-5 parts of fructus forsythia. The drug has the effects of dispelling wind and clearing dampness, improving symptoms, clearing away heat and relieving swelling, dispersing stasis, relieving pain, moisturizing mucosa, shrinking polyp, and the like, is mainly used for treating chronic rhinitis, atrophic rhinitis, nasal polyp and the like. The drug is strong in adaptation, short in course of treatment, good in effect, capable of relieving untoward effect of a patient, especially convenient and effective for treating a child patient.